Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) insider Fernando M. Rodrigues sold 4,174 shares of Teladoc Health stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total transaction of $28,842.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Teladoc Health Price Performance
Shares of Teladoc Health stock traded up $0.35 during trading on Friday, reaching $7.28. 5,275,426 shares of the company's stock were exchanged, compared to its average volume of 6,288,824. The firm's 50-day moving average price is $7.15 and its 200 day moving average price is $9.13. The company has a market cap of $1.28 billion, a P/E ratio of -1.26 and a beta of 1.82. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. Teladoc Health, Inc. has a 1-year low of $6.35 and a 1-year high of $15.21.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on TDOC. Citigroup lowered their target price on Teladoc Health from $11.00 to $8.75 and set a "neutral" rating for the company in a research note on Friday, April 25th. Piper Sandler lowered their target price on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a report on Thursday, February 27th. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Bank of America reduced their target price on Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a report on Wednesday, May 28th. Finally, Evercore ISI reduced their target price on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating on the stock in a report on Thursday, May 1st. Twelve investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $9.60.
Check Out Our Latest Stock Report on TDOC
Institutional Inflows and Outflows
A number of institutional investors have recently modified their holdings of TDOC. Vanguard Group Inc. increased its stake in Teladoc Health by 7.0% during the 1st quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider's stock valued at $157,229,000 after purchasing an additional 1,289,183 shares in the last quarter. Point72 Asset Management L.P. grew its stake in shares of Teladoc Health by 33.6% in the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock worth $101,625,000 after acquiring an additional 2,813,568 shares in the last quarter. Renaissance Technologies LLC grew its position in Teladoc Health by 15.5% during the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock valued at $51,582,000 after buying an additional 763,265 shares during the period. Geode Capital Management LLC raised its holdings in shares of Teladoc Health by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock worth $35,894,000 after purchasing an additional 22,664 shares during the period. Finally, Maple Rock Capital Partners Inc. lifted its position in shares of Teladoc Health by 189.5% during the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock valued at $32,369,000 after buying an additional 2,331,000 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company's stock.
About Teladoc Health
(
Get Free Report)
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
Before you consider Teladoc Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teladoc Health wasn't on the list.
While Teladoc Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
